Kenneth Giraldo
Interventional Pain Management · Sarasota, FLNPI 1326032061
Payments from drug & device makers
Across 86 payments — averaging $418.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Foundation Fusion Solutions, LLC$25K
- Nutech Spine, Inc.$8K
- Nalu Medical, Inc.$1K
- Zentech Inc.$1K
- Boston Scientific$584
- Abbott$138
- plus $471 from 12 others
What the payments were for
- Consulting fees$15,00078%
- Travel & lodging$1,6058%
- Food & beverage$2,55813%
- Entertainment$1031%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Foundation Fusion Solutions, LLC | 41 | $24,963 |
| Nutech Spine, Inc. | 6 | $7,516 |
| Nalu Medical, Inc. | 2 | $1,295 |
| Zentech Inc. | 1 | $1,000 |
| Boston Scientific | 17 | $584 |
| Abbott | 3 | $138 |
| Harmony Biosciences LLC | 4 | $134 |
| Medtronic | 1 | $73 |
| Saluda Medical Americas, Inc. | 1 | $46 |
| Stryker | 1 | $41 |
| Johnson & Johnson | 1 | $38 |
| Spinal Simplicity, LLC | 2 | $36 |
| Scilex Pharmaceuticals Inc. | 1 | $21 |
| Painteq LLC | 1 | $21 |
| SPR Therapeutics, Inc | 1 | $20 |
| Assertio Therapeutics, Inc. | 1 | $17 |
| Almatica Pharma LLC | 1 | $14 |
| Spinefrontier, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SiFix$7,421
- Nalu Neurostimulation System$1,295
- WaveWriter Alpha Prime 16$288
- ETERNA$104
How this compares
Too few interventional pain management providers in Floridato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| NucyntaTapentadol Hcl | 13 | $18,740 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 143 | $5,419 |
| Gabapentin | 440 | $5,086 |
| Oxymorphone Hcl ErOxymorphone Hcl | 12 | $4,802 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 176 | $3,461 |
| Morphine Sulfate | 55 | $3,019 |
| Tramadol Hcl | 330 | $2,414 |
| Morphine Sulfate ErMorphine Sulfate | 86 | $2,128 |
| Pregabalin | 67 | $1,489 |
| Duloxetine Hcl | 31 | $1,093 |
| Hydromorphone Hcl | 63 | $900 |
| Tizanidine Hcl | 65 | $695 |
| Diclofenac Sodium | 35 | $373 |
| Baclofen | 13 | $326 |
| Meloxicam | 64 | $161 |
Paid to pharmacies, not to this prescriber.
Other interventional pain management in Sarasota
- Fernando MirandaWinter Haven$8K
- Alex KhromovDeltona$5K
- Eduardo DieguezSt Augustine$0
- Yamilet NeningerTampa$0
- Witford ReidSebring$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.